Literature search results

347 articles were found.

The following terms were included: Glioblastom, glioblastoma, 神経膠細胞芽腫

• 2021, Ramirez-Fort MK, Naveh A, McClelland 3rd S, Gilman CK, Fort M, Mendez M, Matta J, Bomzon Z, Lange CS
  Computational simulations establish a novel transducer array placement arrangement that extends delivery of therapeutic TTFields to the infratentorium of patients with brainstem gliomas [tech./dosim.]
  Rep Pract Oncol Radiother 26 (6): 1045-1050
• 2021, Sharpe MA, Baskin DS, Pichumani K, Ijare OB, Helekar SA
  Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells [med./bio.]
  Front Oncol 11: 768758
• 2021, Harke S, Manteuffel D
  Lumped Element Model of Spherical Cells Exposed to an External Electric Field [tech./dosim.]
  IEEE J Electromagn RF Microw Med Biol 5 (4): 355-361
• 2021, Arvind R, Chandana SR, Borad MJ, Pennington D, Mody K, Babiker H
  Tumor-Treating Fields: A Fourth Modality in Cancer Treatment, New Practice Updates [basics]
  Crit Rev Oncol Hematol 168: 103535
• 2021, Lee WS, Seo SJ, Chung HK, Park JW, Kim JK, Kim EH
  Tumor-treating fields as a proton beam-sensitizer for glioblastoma therapy [med./bio.]
  Am J Cancer Res 11 (9): 4582-4594
• 2021, Wu H, Yang L, Liu H, Zhou D, Chen D, Zheng X, Yang H, Li C, Chang J, Wu A, Wang Z, Ren N, Lv S, Liu Y, Jia M, Lu J, Liu H, Sun G, Liu Z, Liu J, Chen L
  Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study [med./bio.]
  CNS Neurosci Ther 27 (12): 1587-1604
• 2021, Ram Z, Kim CY, Hottinger AF, Idbaih A, Nicholas G, Zhu JJ
  Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial [med. app.]
  Front Oncol 11: 671972
• 2021, Biswas S, Kapitanova I, Divekar S, Grimm J, Butterwick IJ, Garren D, Kleinberg LR, Redmond KJ, Lacroix M, Mahadevan A, Forster KM
  Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy [dev./impl.]
  Technol Cancer Res Treat 20: 15330338211039135
• 2021, Choi KH, Ha J, Bae S, Lee AK, Choi HD, Ahn YH, Ha M, Joo H, Kwon HJ, Jung KW
  Mobile Phone Use and Time Trend of Brain Cancer Incidence Rate in Korea [epidem.]
  Bioelectromagnetics 42 (8): 629-648
• 2021, Helekar SA, Hambarde S, Ijare OB, Pichumani K, Baskin DS, Sharpe MA
  Selective induction of rapid cytotoxic effect in glioblastoma cells by oscillating magnetic fields [med./bio.]
  J Cancer Res Clin Oncol 147 (12): 3577-3589
• 2021, Lok E, San P, White V, Liang O, Widick PC, Reddy SP, Wong ET
  Tumor Treating Fields for Ovarian Carcinoma: A Modeling Study [tech./dosim.]
  Adv Radiat Oncol 6 (4): 100716
• 2021, Baskin DS, Sharpe MA, Nguyen L, Helekar SA
  Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device [med. app.]
  Front Oncol 11: 708017
• 2021, Jenkins EPW, Finch A, Gerigk M, Triantis IF, Watts C, Malliaras GG
  Electrotherapies for Glioblastoma [basics]
  Adv Sci 8 (18): e2100978
• 2021, Regev O, Merkin V, Blumenthal DT, Melamed I, Kaisman-Elbaz T
  Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis [review]
  Neurooncol Pract 8 (4): 426-440
• 2021, Clancy H, Pruski M, Lang B, Ching J, McCaig CD
  Glioblastoma Cell Migration is Directed by Electrical Signals [med./bio.]
  Exp Cell Res 406 (1): 112736
• 2021, Blatt R, Davidi S, Munster M, Shteingauz A, Cahal S, Zeidan A, Marciano T, Bomzon Z, Haber A, Giladi M, Weinberg U, Kinzel A, Palti Y
  In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso [med./bio.]
  Front Oncol 11: 670809
• 2021, Diamant G, Simchony Goldman H, Gasri Plotnitsky L, Roitman M, Shiloach T, Globerson-Levin A, Eshhar Z, Haim O, Pencovich N, Grossman R, Ram Z, Volovitz I
  T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields [med./bio.]
  J Immunol 207 (2): 709-719
• 2021, Liu S, Shi W, Zhao Q, Zheng Z, Liu Z, Meng L, Dong L, Jiang X
  Progress and prospect in tumor treating fields treatment of glioblastoma [basics]
  Biomed Pharmacother 141: 111810
• 2021, Tanaka S
  [Glioblastoma] [foreign-language]
  No Shinkei Geka 49 (3): 623-631
• 2021, Aguilar AA, Ho MC, Chang E, Carlson KW, Natarajan A, Marciano T, Bomzon Z, Patel CB
  Permeabilizing Cell Membranes with Electric Fields [tech./dosim.]
  Cancers 13 (9): 2283
• 2021, McNamee JP, Grybas VS, Qutob SS, Bellier PV
  Effects of 1800 MHz radiofrequency fields on signal transduction and antioxidant proteins in human A172 glioblastoma cells [med./bio.]
  Int J Radiat Biol 97 (9): 1316-1323
• 2021, Jeong H, Jo Y, Yoon M, Hong S
  Thymidine decreases the DNA damage and apoptosis caused by tumor-treating fields in cancer cell lines [med./bio.]
  Genes Genomics 43 (9): 995-1001
• 2021, Makimoto A, Nishikawa R, Terashima K, Kurihara J, Fujisaki H, Ihara S, Morikawa Y, Yuza Y
  Tumor-Treating Fields Therapy for Pediatric Brain Tumors [review]
  Neurol Int 13 (2): 151-165
• 2021, Oberacker E, Diesch C, Nadobny J, Kuehne A, Wust P, Ghadjar P, Niendorf T
  Patient-Specific Planning for Thermal Magnetic Resonance of Glioblastoma Multiforme [tech./dosim.]
  Cancers 13 (8): 1867
• 2021, García-Minguillán O, Maestú C
  [details] 30 Hz, Could It Be Part of a Window Frequency for Cellular Response? [review]
  Int J Mol Sci 22 (7): 3642
• 2021, Iwamoto KS, Sandstrom RE, Bryan M, Liu Y, Elgart SR, Sheng K, Steinberg ML, McBride WH, Low DA
  Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy [med./bio.]
  Adv Radiat Oncol 6 (3): 100645
• 2021, Han H, Oberacker E, Kuehne A, Wang S, Eigentler TW, Grass E, Niendorf T
  Multi-Channel RF Supervision Module for Thermal Magnetic Resonance Based Cancer Therapy [tech./dosim.]
  Cancers 13 (5): 1001
• 2021, Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS
  Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression [med./bio.]
  Neoplasia 23 (1): 58-67
• 2021, Rominiyi O, Vanderlinden A, Clenton SJ, Bridgewater C, Al-Tamimi Y, Collis SJ
  [details] Tumour treating fields therapy for glioblastoma: current advances and future directions [review]
  Br J Cancer 124 (4): 697-709
• 2021, Karanam NK, Story MD
  An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications [basics]
  Int J Radiat Biol 97 (8): 1044-1054
• 2021, Gentilal N, Salvador R, Miranda PC
  A Thermal Study of Tumor-Treating Fields for Glioblastoma Therapy [tech./dosim.]
  Brain and Human Body Modeling 2020. Springer, Cham (CH): pp. 37-62; ISBN 978-3-030-45622-1
• 2021, Bomzon Z, Wenger C, Proescholdt M, Mohan S
  Tumor-Treating Fields at EMBC 2019: A Roadmap to Developing a Framework for TTFields Dosimetry and Treatment Planning [basics]
  Brain and Human Body Modeling 2020. Springer, Cham (CH): pp. 3-17; ISBN 978-3-030-45622-1
• 2021, Orlacchio R, Carr L, Palego C, Arnaud-Cormos D, Leveque P
  High-voltage 10 ns delayed paired or bipolar pulses for in vitro bioelectric experiments [tech./dosim.]
  Bioelectrochemistry 137: 107648
• 2021, Dehghani-Soltani S, Eftekhar-Vaghefi SH, Babaee A, Basiri M, Mohammadipoor-Ghasemabad L, Vosough P, Ahmadi-Zeidabadi M
  Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O6-Methylguanine-DNA Methyltransferase, Cyclin-D1, and p53 [med./bio.]
  Cancer Biother Radiopharm 36 (7): 579-587
• 2021, Berger TR, Wong ET
  Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies [basics]
  Chin Clin Oncol 10 (4): 36
• 2020, Carrieri FA, Smack C, Siddiqui I, Kleinberg LR, Tran PT
  [details] Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment [review]
  Front Oncol 10: 575992
• 2020, Ravin R, Cai TX, Pursley RH, Garmendia-Cedillos M, Pohida T, Freidlin RZ, Wang H, Zhuang Z, Giles AJ, Williamson NH, Gilbert MR, Basser PJ
  A novel in vitro device to deliver induced electromagnetic fields to cell and tissue cultures [med./bio.]
  Biophys J 119 (12): 2378-2390
• 2020, Crawford J, Saria MG, Dhall G, Margol A, Kesari S
  Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series [med. app.]
  Cureus 12 (10): e10804
• 2020, Kim JY, Jo Y, Oh HK, Kim EH
  Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3 [med./bio.]
  Am J Cancer Res 10 (10): 3475-3486
• 2020, Voloshin T, Schneiderman RS, Volodin A, Shamir RR, Kaynan N, Zeevi E, Koren L, Klein-Goldberg A, Paz R, Giladi M, Bomzon Z, Weinberg U, Palti Y
  Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics [med./bio.]
  Cancers 12 (10): E3016
• 2020, Oh JY, Lee YJ, Kim EH
  Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells [med./bio.]
  Technol Cancer Res Treat 19: 1533033820947481
• 2020, Gentilal N, Miranda PC
  Heat transfer during TTFields treatment: Influence of the uncertainty of the electric and thermal parameters on the predicted temperature distribution [tech./dosim.]
  Comput Methods Programs Biomed 196: 105706
• 2020, Ghiaseddin AP, Shin D, Melnick K, Tran DD
  Tumor Treating Fields in the Management of Patients with Malignant Gliomas [basics]
  Curr Treat Options Oncol 21 (9): 76
• 2020, Ashta A, Motalleb G, Ahmadi-Zeidabadi M
  Evaluation of frequency magnetic field, static field, and Temozolomide on viability, free radical production and gene expression (p53) in the human glioblastoma cell line (A172) [med./bio.]
  Electromagn Biol Med 39 (4): 298-309
• 2020, Tsai HF, IJspeert C, Shen AQ
  Voltage-gated ion channels mediate the electrotaxis of glioblastoma cells in a hybrid PMMA/PDMS microdevice [med./bio.]
  APL Bioeng 4 (3): 036102
• 2020, Kissling C, Di Santo S
  Tumor Treating Fields - behind and beyond inhibiting the cancer cell cycle [review]
  CNS Neurol Disord Drug Targets 19 (8): 599-610
• 2020, Shah PP, White T, Khalafallah AM, Romo CG, Price C, Mukherjee D
  A systematic review of tumor treating fields therapy for high-grade gliomas [review]
  J Neurooncol 148 (3): 433-443
• 2020, Shi W, Blumenthal DT, Oberheim Bush NA, Kebir S, Lukas RV, Muragaki Y, Zhu JJ, Glas M
  Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice [med. app.]
  J Neurooncol 148 (3): 489-500
• 2020, Li X, Yang F, Gao B, Yu X, Rubinsky B
  A Theoretical Analysis of the Effects of Tumor-Treating Electric Fields on Single Cells [tech./dosim.]
  Bioelectromagnetics 41 (6): 438-446
• 2020, Oberacker E, Kuehne A, Oezerdem C, Nadobny J, Weihrauch M, Beck M, Zschaeck S, Diesch C, Eigentler TW, Waiczies H, Ghadjar P, Wust P, Winter L, Niendorf T
  Radiofrequency applicator concepts for thermal magnetic resonance of brain tumors at 297 MHz (7.0 Tesla) [tech./dosim.]
  Int J Hyperthermia 37 (1): 549-563